Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+21.8%
5Y CAGR+20.5%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+21.8%/yr
vs +31.5%/yr prior
5Y CAGR
+20.5%/yr
Consistent
Acceleration
-9.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.5x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.24B | +25.6% |
| 2024 | $1.78B | +9.1% |
| 2023 | $1.64B | +32.0% |
| 2022 | $1.24B | +20.2% |
| 2021 | $1.03B | +16.8% |
| 2020 | $882.90M | +23.3% |
| 2019 | $715.80M | +72.7% |
| 2018 | $414.40M | +41.4% |
| 2017 | $292.99M | +80.4% |
| 2016 | $162.37M | - |